Jane Street
PRCT icon

Jane Street’s Procept Biorobotics PRCT Stock Holding History

Jane Street’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.24M Buy
129,700
+85,900
+196% +$2.42M ﹤0.01% 4206
2025
Q4 		$1.38M Buy
43,800
+5,000
+13% +$166K ﹤0.01% 5498
2025
Q3 		$1.38M Sell
38,800
-16,100
-29% -$735K ﹤0.01% 5635
2025
Q2 		$3.16M Sell
54,900
-17,400
-24% -$984K ﹤0.01% 3674
2025
Q1 		$4.21M Buy
72,300
+11,100
+18% +$758K ﹤0.01% 3183
2024
Q4 		$4.93M Buy
61,200
+44,200
+260% +$3.78M ﹤0.01% 2685
2024
Q3 		$1.36M Sell
17,000
-45,500
-73% -$3.23M ﹤0.01% 5252
2024
Q2 		$3.82M Sell
62,500
-82,200
-57% -$4.89M ﹤0.01% 3395
2024
Q1 		$7.15M Buy
144,700
+30,200
+26% +$1.44M ﹤0.01% 2168
2023
Q4 		$4.8M Buy
114,500
+106,100
+1,263% +$3.61M ﹤0.01% 2912
2023
Q3 		$276K Sell
8,400
-41,600
-83% -$1.42M ﹤0.01% 7183
2023
Q2 		$1.77M Sell
50,000
-1,000
-2% -$33.1K ﹤0.01% 4346
2023
Q1 		$1.45M Buy
+51,000
New +$1.8M ﹤0.01% 4356

Other funds holding PRCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jane Street's PRCT Position: Q1 2026 in Review

Jane Street sold out of Procept Biorobotics (PRCT) in Q1 2026, closing a stake of 27,497 shares — an estimated $775K sold.

Jane Street first reported a position in PRCT in Q2 2022 and held it in 11 quarters. The position peaked at $6.65M in Q2 2024. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Jane Street reported no remaining Procept Biorobotics position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 27,497 Procept Biorobotics shares in Q1 2026, an estimated $775K.
  • Jane Street first reported a position in Procept Biorobotics in Q2 2022 and held it in 11 quarters.
  • Jane Street's Procept Biorobotics position peaked at $6.65M in Q2 2024.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.